Adverse clinical outcomes (data are number (%) and odds ratio (95% confidence intervals))
| All infants | Surviving infants | ||||||
|---|---|---|---|---|---|---|---|
| Control group (n=122) | Experimental group (n=123) | Odds ratio | Control group (n=106) | Experimental group (n=104) | Odds ratio | ||
| Death | 16 (13%) | 19 (15%) | 1.210 (0.590-2.481) | ||||
| Ventilator dependent day 15 | 27 (22%) | 24 (20%) | 0.853 (0.460-1.582) | 25 (24%) | 18 (17%) | 0.678 (0.344-1.335) | |
| O2 dependent 36 weeks | 24 (20%) | 23 (19%) | 0.832 (0.436-1.588) | 24 (23%) | 19 (18%) | 0.688 (0.346-1.366) | |
| Pneumothorax | 11 (9%) | 9 (7%) | 0.797 (0.318-1.997) | 8 (8%) | 5 (5%) | 0.619 (0.196-1.957) | |
| PIE | 12 (10%) | 10 (8%) | 0.811 (0.337-1.954) | 7 (7%) | 3 (3%) | 0.420 (0.106-1.671) | |
| Pulmonary haemorrhage | 10 (8%) | 7 (6%) | 0.676 (0.249-1.837) | 5 (5%) | 1 (1%) | 0.196 (0.023-1.708) | |
| Abnormal USS at 6 weeks | 14 (11%) | 18 (15%) | 1.612 (0.744-3.492) | 11 (10%) | 15 (14%) | 1.763 (0.754-4.126) | |
| Any adverse event | 55 (45%) | 55 (45%) | 0.985 (0.596-1.630) | 39 (37%) | 36 (35%) | 0.869 (0.509-1.577) | |